Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Breast Cancer

Summary

This is a phase II trial evaluating intra-hepatic chemotherapy with oxaliplatin every second week in combination with systemic capecitabine and in patients with a HER2-positive tumour in combination with trastuzumab (Herceptin®) in patient with non-resectable liver metastases from breast cancer. Only patients without extrahepatic disease are included.

Timeline

Start

2010-04

Primary completion

2017-05-01

Completion

2017-09-01

Drugs

Indications